4//SEC Filing
Drape Eric 4
Accession 0000950170-24-028002
CIK 0000818686other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:24 PM ET
Size
11.3 KB
Accession
0000950170-24-028002
Insider Transaction Report
Form 4
Drape Eric
Executive VP Global Operations
Transactions
- Exercise/Conversion
Ordinary Shares
2024-03-05+22,576→ 90,689 total - Exercise/Conversion
Restricted Share Units
2024-03-05−22,576→ 22,576 total→ Ordinary Shares (22,576 underlying) - Exercise/Conversion
Restricted Share Units
2024-03-05−55,226→ 0 total→ Ordinary Shares (55,226 underlying) - Exercise/Conversion
Ordinary Shares
2024-03-05+55,226→ 145,915 total
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Amount reflects the sale of 9,815 Ordinary Shares by the Reporting Person, as reported in a Form 4 filed on March 1, 2024, which was inadvertently omitted from the amount of securities beneficially owned by the Reporting Person following the transactions reported in a Form 4 filed on March 5, 2024.
- [F4]Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022, March 5, 2023, March 5, 2024 and 22,576 vesting on March 5, 2025.
- [F5]Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001790905
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:24 PM ET
- Size
- 11.3 KB